NT-proBNP as a Marker for Persistent Cardiac Disease in Children with History of Dilated Cardiomyopathy and Myocarditis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bettuzzi MG, Colaneri M, Ricciotti R, et al. (2004) Plasma natriuretic peptides in neonates and children with congenital heart disease: correlation with ventricular function, heart failure symptoms and cardiac anatomy [abstract]. Cardiol Young 14(Suppl 2):34
Calabrese F, Thiene G (2003) Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 60:11–25
Connolly D, Rutkowski M, Auslender M, Artman M (2000) The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. J Pediatr 138:644–648
Espiner EA, Richards AM, Yandle TG, Nicholls MG (1995) Natriuretic hormones. Endocrinol Metab Clin North Am 24:481–509
Friedman RA, Schowengerdt KO, Towbin JA (1998) Myocarditis. In: Garson A, Bricker JT, Fischer D, Neish S (eds) The Science and Practice of Pediatric Cardiology, 2nd edn, Willams & Wilkins, Baltimore, pp 1777–1794
Karl J, Borgya A, Gullusser A, et al (1999) Development of a novel. N-terminal-proBNP (NT-proBNP) assay with a low detection limit. Scan J Clin Lab Invest 59(Suppl 230):177–181
Lubien E, DeMaria A, Krishnaswamy P, et al (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105:595–601
Mair J, Hammerer-Lercher A, Puschendorf B (2001) The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 39:571–588
Maron BJ, Isner JM, McKenna WJ (1994) Task force 3 hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse. J Am Coll Cardiol 24:854–899
Masson S, Vago T, Baldi G, et al. (2002) Comparative measurement of N-terminal-brain natriuretic peptide and brain natriuretic peptide in ambulatory patients with heart failure. Clin Chem Lab Med 40:761–763
Matitiau A, Perez-Atayde A, Sanders SP, et al. (1994) Infantile dilated cardiomyopathy. Relation of outcome to left ventricular mechanics, hemodynamics and histology at the time of diagnosis. Circulation 90:1310–1318
McGeoch G, Lainchbury J, Town GI, et al (2002) Plasma brain natriuretic peptide after long-term treatment for heart failure in general practice. Eur J Heart Failure 4:479–483
Mir TS, Marohn S, Laer S, et al (2002) Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 110:e76
Nir A, Bar-Oz B, Perles Z, et al. (2004) N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in heart diseases. Acta Paediatr 93:603–607
Ohuchi H, Takasugi H, Ohashi H, et al. (2003) Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation 108:2368–2376
Richards AM, Doughty R, Nicholls G, et al (2001) Australia–New Zealand heart failure group. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin. Prognostic utility and prediction of benefit from carvedilol in chronic left ventricular dysfunction. J Am Coll Cardiol 37:1781–1787
Suda K, Matsumura M, Matsumoto M (2003) Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 45: 249–254
Tisseres P, Aggoun Y, Sierra J, et al. (2004) Comparison of the New York Heart Association (NYHA), Ross, and Pediatric Heart Failure Index (PHFI) classifications in children with left ventricular dysfunction secondary to valvular disease. Biochemical and echocardiographic correlation [abstract]. Cardiol Young 14(Suppl 2):36